Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats. - Wikidata - awgldk - TriplyDB

Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.

Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.

http://www.wikidata.org/entity/Q37150782

about

High-frequency ultrasound imaging to evaluate liver fibrosis progression in rats and yi guan jian herbal therapeutic effects.Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis.Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria.MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide.

P2860

Q30447084-50AC2DD5-1B89-4A0B-8AFD-D51AC87A65BB Q36165804-8C048574-9ED2-4EA2-8B2E-BD53FDF03602 Q50440696-7FF3330F-B53E-4770-AF96-EEE5A9191D92 Q50441063-6E5974D2-4397-4675-82EF-A21DA91DA45E

P2860

Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.

http://www.wikidata.org/entity/Q37150782

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@en

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@nl

type

label

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@en

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@nl

prefLabel

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@en

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@nl

P1433

Q37150782-D1E28C59-2CE6-4F26-B419-CF3EBF9058E0

P1476

Q37150782-9D32023D-89AF-4AB4-9DE5-3F91D982001C

P2093

Q37150782-2D7CA624-1BF8-4058-99A7-5C557B66EDD4

Q37150782-61B0EB27-7B8C-4CA9-877D-16C8ACDDA0EE

Q37150782-97FE1004-7253-453B-90AB-BB7833B8D03A

Q37150782-9CA1BFEB-1A9C-46C0-BCF8-F77327AC662F

Q37150782-B64BE488-EF22-41E1-86D0-C7FF01204340

Q37150782-BA64F8AB-68C8-4E3C-9B13-121BD695287F

Q37150782-C1129484-D155-401B-91D1-D79C137B388C

Q37150782-C8B7F4EA-2E29-43E3-8EE2-17828F7DB734

Q37150782-D61C118D-A803-4CEC-8D64-80B8AEDB20F3

Q37150782-DA8455F6-5900-47B8-8A2E-2B3C72E816FF

P2860

Q37150782-117E8760-602A-4C44-B7A5-D36D513420AF

Q37150782-1232A483-6545-4065-9025-DE8E1B5616D9

Q37150782-159D074F-FA77-4425-92BE-BB95D4700AD2

Q37150782-1BE3E222-9CC3-47FE-81D9-0EF9A2B4E54C

Q37150782-1CC88952-3B7A-4466-AA72-8FE401D247BA

Q37150782-21C5584B-A7F3-4257-B415-585D363B8D0A

Q37150782-22C1E701-EDE6-450F-8B1F-585729947485

Q37150782-3F4227C5-1F46-4038-9A93-C5F6CE564F6A

Q37150782-3FCF6E32-C117-45E1-A603-790F63C220AC

Q37150782-3FFAA6CD-296B-474D-86E9-B51D84222D58

P304

Q37150782-0DD46BE7-7D08-4C17-9100-F072CB7E574F

P31

Q37150782-C6527DCE-6B34-4904-B294-E4E5698D9F47

P356

Q37150782-1C6406F3-8C46-49F9-8332-9A63C9E1C3C4

P407

Q37150782-D3F58B21-252F-412D-882C-3FACD755269E

P433

Q37150782-54BA51E5-C309-401F-8DA6-7804557EF63C

P478

Q37150782-127BD18F-8868-4352-BBB7-2B051E4D52F8

P577

Q37150782-5C4C2C33-CE0A-465A-B60F-43678433334B

P5875

Q37150782-4347B2E5-A3DE-4099-9629-E51FE5B24B49

P698

Q37150782-6155A93C-3D42-4F72-BF51-2D21C98ACF9D

P932

Q37150782-A601E813-16CA-4125-81DC-4C426F72F8FB

P356

AJPATH.2009.080261

P1433

The American Journal of Pathology

P1476

Suppressive effect of orthovan ...... on and liver fibrosis in rats.

@en

P2093

Akiko Yagisawa

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Enomoto

http://www.w3.org/2001/XMLSchema#string

Masayuki Yoshida

http://www.w3.org/2001/XMLSchema#string

Naoto Ohi

http://www.w3.org/2001/XMLSchema#string

Takuo Tokairin

http://www.w3.org/2001/XMLSchema#string

Toshiaki Yoshioka

http://www.w3.org/2001/XMLSchema#string

Yasufumi Omori

http://www.w3.org/2001/XMLSchema#string

Yohei Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yuji Nishikawa

http://www.w3.org/2001/XMLSchema#string

Yuko Doi

http://www.w3.org/2001/XMLSchema#string

P2860

Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity

Src kinase regulation by phosphorylation and dephosphorylation

c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells

Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase

Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA

c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation

A src family tyrosine kinase inhibits neurotransmitter release from neuronal cells.

Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

P304

881-890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2009.080261

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23933646

http://www.w3.org/2001/XMLSchema#string

P698

19164509

http://www.w3.org/2001/XMLSchema#string

P932

2665748

http://www.w3.org/2001/XMLSchema#string